We’re looking for a candidate to this position in an exciting company.
Build a team of statisticians to establish the new capability in supporting oncology medical and market access book of work
Collaborate with VEO, medical and commercial organization to deliver a large and diverse book of work, across all GSK oncology marketed products and late stage pipeline assets with regards to non-registrational data generation, market access, publication and scientific congress support, ISR review, for identifying important new opportunities, developing responses to scientific requests for information from health care providers, key opinion leaders and bodies of Health Technology Assessment.
Addressed challenges in market access and reimbursement raised by regional agencies such as the Institute for Quality and Efficiency in Health Care (IQWiG) and Federal Joint Committee (G-BA) in Germany, UK National Institute for Health and Clinical Excellence (NICE), France Haute Autorité de Santé (HAS) and Australia Pharmaceutical Benefits Advisory Committee (PBAC), in collaboration with other functions
Partner with RU statisticians to participate in the review of Investigator Sponsored trials and GSK sponsored Phase IV trials (including post marketing commitments).
Formulate a data strategy to effectively leverage both internal and external data analyses to inform R&D oncology organization for potential future development opportunities
Collaborate with global/regional Health Economics and Market Access Teams on identifying analysis methods and interpretation of observation data and other real-world type data (such as Patient Registries and Claims Data Bases).
Invests in developing knowledge outside of conventional statistical expertise in the clinical, regulatory and commercial environments.
Influence planning and decision-making strategy over a portfolio of assets through building and maintaining effective business relationships with VEO, medical and commercial organizations.
Serve as a member of the Oncology Biostatistics Leadership Team.
PhD in Statistics or closely related field
Ability to drive and influence strategic direction
Exceptional capability to influence leadership.
Familiarity with regulatory interactions and pathways.
Embedding talent management throughout the team
Provide constructive feedback to enable team members to perform to their optimum
Create and lead an empowered, motivated team where diversity of thought is encouraged.
Track record of strong statistical contributions and accomplishments in clinical drug development, with a broad knowledge of all phases of drug development (pre-clinical; Phase I-IV).
Demonstrated ability to lead or make major contributions to department, organizational and/or industry-wide initiatives, through effective communication and influence.
Expertise in a range of statistical methodologies with application to real problems